Could a simple sensor transform diabetes care for african youth?

NCT ID NCT05454176

Recruiting now Disease control Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a flash continuous glucose monitor (CGM) can help children and young adults in Uganda with type 1 diabetes keep their blood sugar in a healthy range more often than standard finger-prick testing. Half of the 180 participants will use the CGM for the first six months, while the other half will use standard testing. After six months, the groups switch. The study also looks at whether the CGM is cost-effective in a low-resource country.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FreeStyle Libre 2 continuous glucose monitor (CGM)
What this could lead to: If successful, this could show that flash CGM is a practical and cost-effective tool to help young people in low-resource settings manage their diabetes better.
What could go wrong: This is a Phase 4 trial with 180 participants, so results may not apply to all populations. The device requires consistent use and access to supplies, which could be challenging in some settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE1DIABETES

Contacts and locations

Locations

University of Minnesota
RECRUITING

Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.